Coronary stenosis is a risk marker for impaired cardiac function on cardiopulmonary exercise test

Siyuan Li1, Yifang Yuan2,3, Lanting Zhao1

  • 1Department of Cardiology, Beijing Tsinghua Changgung Hospital, 168# Litang Road, 102218, Beijing, China.

Insights

Cardiac function, including oxygen uptake and heart rate, is reduced in ischemic heart disease (IHD) patients. Even non-obstructive coronary artery disease (NOCAD) shows impaired cardiac output, warranting early prevention and monitoring.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Medical Diagnostics

Background:

  • Ischemic heart disease (IHD) presents with varied cardiac functional changes.
  • Understanding these variations based on coronary stenosis severity is crucial for patient management.

Purpose of the Study:

  • To evaluate cardiac function characteristics using cardiopulmonary exercise testing (CPET) in IHD patients with differing degrees of coronary artery stenosis.
  • To compare CPET-derived cardiac function metrics across non-obstructive (NOCAD), obstructive (OCAD), and severe obstructive (severe OCAD) coronary artery disease categories.

Main Methods:

  • 614 IHD patients were categorized by coronary angiography: NOCAD (<50% stenosis), OCAD (50-90% stenosis), and severe OCAD (>90% stenosis).
  • 101 healthy volunteers served as controls.
  • All participants underwent CPET to measure oxygen uptake (VO2), cardiac output (CO), and heart rate (HR).

Main Results:

  • IHD patients generally exhibited lower VO2, CO, and HR compared to controls.
  • Significant reductions in VO2 peak, CO, and HR were observed across all IHD groups (NOCAD, OCAD, severe OCAD) compared to controls (P<0.05).
  • NOCAD patients showed significantly lower VO2 at anaerobic threshold and VO2 peak compared to healthy volunteers after adjustment, alongside low stroke volume and inefficient gas exchange in all IHD patients.

Conclusions:

  • Increasing atherosclerotic burden in IHD correlates with impaired cardiac output and chronotropic response during CPET.
  • Non-obstructive coronary artery disease (NOCAD) demonstrates measurable cardiac dysfunction, necessitating enhanced early prevention strategies and diligent follow-up.
Abstract

Related Concept Videos

Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
366
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
26
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
139